Chronic traumatic encephalopathy.
Behavioural symptoms
Cognitive decline
Neurodegeneration
Tauopathy
Traumatic brain injury
Journal
Neuro-Chirurgie
ISSN: 1773-0619
Titre abrégé: Neurochirurgie
Pays: France
ID NLM: 0401057
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
14
12
2020
revised:
07
02
2021
accepted:
13
02
2021
pubmed:
24
2
2021
medline:
22
6
2021
entrez:
23
2
2021
Statut:
ppublish
Résumé
Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease linked to repeated traumatic brain injury (TBI). This disorder is mainly observed in subjects at risk for brain traumatisms including boxers, American football and European football (soccer) players, as well as war veterans. Neuropathological findings are marked by abnormally phosphorylated tau accumulations at the depth of cerebral sulci, as well as TDP43, Aβ and α-synuclein positive staining. It has been described 3 clinical variants: the behavioural/mood variant, the cognitive variant and the mixed behavioural/cognitive variant. Cerebral MRI revealed signs of diffuse atrophy with abnormal axonal findings using the diffusion tensor imaging methods. Cerebral PET tau revealed increased standardised uptake value ratio (SUVR) levels in various brain regions of CTE patients compared to controls. The place of CTE among other neurodegenerative diseases is still debated. The focus of CTE management must be on prevention. The best way to prevent CTE in athletes is to put in place strict and appropriate measures by physicians. An individual with concussion should not be allowed to play again immediately (and sometimes never) in cases of abnormal neurological symptoms or imaging abnormalities.
Identifiants
pubmed: 33621530
pii: S0028-3770(21)00042-4
doi: 10.1016/j.neuchi.2021.02.003
pii:
doi:
Substances chimiques
Biomarkers
0
MAPT protein, human
0
tau Proteins
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
290-294Informations de copyright
Copyright © 2021 Elsevier Masson SAS. All rights reserved.